ACSLX | VIGAX | ACSLX / VIGAX | |
Total Expense Ratio | 1.90 | 0.05 | 3,800% |
Annual Report Gross Expense Ratio | 1.98 | 0.05 | 3,960% |
Fund Existence | 22 years | 25 years | - |
Gain YTD | -1.562 | 1.951 | -80% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 5.79B | 294B | 2% |
Annual Yield % from dividends | 0.00 | 0.46 | - |
Returns for 1 year | 1.88 | 12.60 | 15% |
Returns for 3 years | 32.58 | 91.62 | 36% |
Returns for 5 years | 25.32 | 115.22 | 22% |
Returns for 10 years | 61.53 | 286.59 | 21% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
AHSZX | 19.03 | -0.11 | -0.57% |
Alger Health Sciences Z | |||
GSNPX | 20.74 | -0.25 | -1.19% |
Goldman Sachs International Eq Inc P | |||
SUSSX | 14.77 | -0.19 | -1.27% |
State Street Instl US Equity Svc | |||
BBIEX | 14.55 | -0.21 | -1.42% |
Bridge Builder International Equity | |||
MXKJX | 8.27 | -0.12 | -1.43% |
Empower Mid Cap Value Instl |